Cardiovascular disease (CVD) is the number one cause of death globally, representing almost one third of all deaths (World Health Organization 2019). There are devastating consequences for both patients and their families, as well as overwhelming healthcare expenditures. CVD costs the Norwegian economy more than 120 NOK billion per year. Long-term management of chronic CVD is an especially high fraction of these costs. Echocardiography (echo) is the primary imaging tool for cardiologists to assess cardiac function and structures. It is essential in evaluating and monitoring chronic and acute cardiac disease as it provides a low cost, mobile and real-time view into the heart. Echo can be used to visualize and quantify overall structure and function of the heart, cardiac muscle, valves, pathologies and blood flow. The vision for this project is to create an innovative new product offering: ECHOcardiography diAgnostic Interpration system(ECHO AI) Echo AI will utilize artificial intelligence to provide workflow improvements by seamlessly integrating image acquisition, analysis and reporting. It will maximize consistency, accuracy, and completeness in accordance with established clinical guidelines. This will be done by developing fully automatic measurements and interpretation of cardiac images originating from an ultrasound scanner. The automated analysis will, in combination with established clinical guidelines, lead to a set of clinical findings. The new product offering will allow for a new and more efficient workflow, where the physician starts with a pre-populated report and can drill down from the high-level findings to individual measurements and images that the findings are based on.
Project leader: Erik Normann Steen
Institution: GE VINGMED ULTRASOUND AS